10x Genomics, Inc. (TXG)

10x Genomics Revenue

10x Genomics had revenue of $150.67M in the quarter ending September 30, 2026, with 1.12% growth. This brings the company's total for the last twelve months to $618.58M, down -3.62% year-over-year. In the year 2025, 10x Genomics had annual revenue of $642.82M with 5.25% growth. That makes 10x Genomics the 10,070th largest company in the world by revenue and 2,159th in the United States.

• Revenue (ttm): $618.58M
• Revenue Growth: -3.62%
• P/S Ratio: 13.83
• Revenue / Employee: $525,107
• Employees: 1,178
• Market Cap: 8.56B

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Single Cell Consumables 363.21M 56.5%
• Spatial Consumables 143.98M 22.4%
• License and Royalty 46.14M 7.2%
• Spatial Instruments 34.11M 5.3%
• Services 32.73M 5.1%
• Single Cell Instruments 22.67M 3.5%

By Geography

Chart

• United States 346.51M 53.9%
• Europe, Middle East and Africa 161.72M 25.2%
• China 70.26M 10.9%
• Asia-Pacific (ex-China) 52.07M 8.1%
• North America (ex-United States) 12.26M 1.9%

Fiscal year ended Dec 31, 2025 See the full 10x Genomics breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	642.82M	32.04M	5.25%
Dec 31, 2024	610.79M	-7.94M	-1.28%
Dec 31, 2023	618.73M	102.32M	19.81%
Dec 31, 2022	516.41M	25.92M	5.28%
Dec 31, 2021	490.49M	191.65M	64.13%
Dec 31, 2020	298.85M	52.95M	21.53%
Dec 31, 2019	245.89M	99.58M	68.06%
Dec 31, 2018	146.31M	75.23M	105.83%
Dec 31, 2017	71.09M	-	-

Data Source: Fiscal.ai Last updated: Nov 5, 2026

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 10, 2026

Data Sources Report a data error